Low Radiation Doses to Gross Tumor Volume in Metabolism Guided Lattice Irradiation Based on Lattice-01 Study: Dosimetric Evaluation and Potential Clinical Research Implication.
Giuseppe Iatì, Giacomo Ferrantelli, Stefano Pergolizzi, Gianluca Ferini, Valeria Venuti, Federico Chillari, Miriam Sciacca, Valentina Zagardo, Carmelo Siragusa, Anna Santacaterina, Anna Brogna, Silvana Parisi
Abstract
Open AccessPurpose: This paper aims to calculate the gross tumor volume (GTV) receiving low radiation doses in patients submitted to "metabolism-guided" lattice radiation therapy and relative possible implications with clinical outcomes. Material and Methods: We reviewed plans for treating voluminous masses via "metabolism-guided" LATTICE-01 irradiation. The aim was to deliver high-dose radiation to spherical deposits (vertices) within a bulky tumor mass. These were placed at tumor areas with differing PET metabolism. We evaluated the relationships between GTV volumes and dose-volumetric histograms (mean, maximum, minimum, and % GTV received 0.5, 1, 2, 3 Gy). Results: Sixty-two plans of treatment met the inclusion criteria as established. The median GTV volume was 315.9 cc (range = 10.54-2605.9 cc). A median of two Vertices was allocated within the GTVs (range 1-9) and were planned to receive a dose of ≥10 Gy/1 fraction (median 12 Gy, range 10-15 Gy). Median V3Gy percentage was 51.58% (range 2-100%), median V2Gy percentage was 67.80% (range 1.60-100%), median V1Gy percentage was 83.70% (range 0.80-100%), and median V0.5Gy percentage was 88.49% (range 17.60-100%). Conclusions: In the present series, we performed a dosimetric evaluation of the GTV's volume exposed to low doses during the metabolic guided lattice irradiation process. Combining high- and low-dose radiotherapy based on a spatially fractionated (LATTICE) approach could reactivate the immune system against cancer cells. These observations could be useful for planning prospective studies on immunotherapy combined with the lattice technique.